Human Pharmaceuticals in the Environment Current and Future Perspectives

Fish on Prozac. Drugs found in drinking water. India’s drug problem. Chances are you’ve seen these headlines. Human pharmaceuticals represent environmental contaminants of emerging concern, and receive unprecedented attention from the scientific, regulatory and public sectors.  This timely contribut...

Full description

Bibliographic Details
Other Authors: Brooks, Bryan W. (Editor), Huggett, Duane B. (Editor)
Format: eBook
Language:English
Published: New York, NY Springer New York 2012, 2012
Edition:1st ed. 2012
Series:Emerging Topics in Ecotoxicology, Principles, Approaches and Perspectives
Subjects:
Online Access:
Collection: Springer eBooks 2005- - Collection details see MPG.ReNa
LEADER 03172nmm a2200349 u 4500
001 EB000364301
003 EBX01000000000000000217353
005 00000000000000.0
007 cr|||||||||||||||||||||
008 130626 ||| eng
020 |a 9781461434733 
100 1 |a Brooks, Bryan W.  |e [editor] 
245 0 0 |a Human Pharmaceuticals in the Environment  |h Elektronische Ressource  |b Current and Future Perspectives  |c edited by Bryan W. Brooks, Duane B. Huggett 
250 |a 1st ed. 2012 
260 |a New York, NY  |b Springer New York  |c 2012, 2012 
300 |a VIII, 304 p  |b online resource 
505 0 |a Perspectives on Human Pharmaceuticals in the Environment -- Environmental Risk Assessment for Human Pharmaceuticals – the Current State of International Regulations -- Regulation of Pharmaceuticals in the Environment: The United States -- Environmental Fate of Human Pharmaceuticals -- Environmental Comparative Pharmacology: Theory and Application -- A Look Backwards at Environmental Risk Assessment: An Approach to Reconstructing Ecological Exposures -- Considerations and Criteria for the Incorporation of Mechanistic Sub-Lethal Endpoints into Environmental Risk Assessment for Biologically Active Compounds -- Human Health Risk Assessment for Pharmaceuticals in the Environment: Existing Practice, Uncertainty, and Future Directions -- Wastewater and Drinking Water Treatment Technologies -- Pharmaceutical Take Back Programs -- Index 
653 |a Environmental chemistry 
653 |a Environmental management 
653 |a Analytical chemistry 
653 |a Environmental Chemistry 
653 |a Analytical Chemistry 
653 |a Pharmacology 
653 |a Environmental Management 
700 1 |a Huggett, Duane B.  |e [editor] 
041 0 7 |a eng  |2 ISO 639-2 
989 |b Springer  |a Springer eBooks 2005- 
490 0 |a Emerging Topics in Ecotoxicology, Principles, Approaches and Perspectives 
028 5 0 |a 10.1007/978-1-4614-3473-3 
856 4 0 |u https://doi.org/10.1007/978-1-4614-3473-3?nosfx=y  |x Verlag  |3 Volltext 
082 0 |a 577.14 
520 |a Fish on Prozac. Drugs found in drinking water. India’s drug problem. Chances are you’ve seen these headlines. Human pharmaceuticals represent environmental contaminants of emerging concern, and receive unprecedented attention from the scientific, regulatory and public sectors.  This timely contribution, prepared by international experts in the field, synthesizes and critically examines topics ranging from regulations, environmental chemistry and exposure analysis, to comparative pharmacology, environmental toxicology, water treatment technologies and pharmaceutical take back programs. Compared to historical contaminants, chemical and biological attributes of human pharmaceuticals present unique challenges to environmental management, but lessons learned from the study of pharmaceuticals promise to advance prospective and retrospective approaches to assess the impacts of industrial chemicals. Students and environmental scientists, managers, regulators, and public health professionals will benefit from this forward-thinking treatment of human pharmaceuticals in the environment